3 results on '"Pherwani, Simran"'
Search Results
2. Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation.
- Author
-
Pherwani, Simran, Connolly, David, Sun, Qiuyu, Karwi, Qutuba G., Carr, Michael, Ho, Kim L., Wagg, Cory S., Zhang, Liyan, Levasseur, Jody, Silver, Heidi, Dyck, Jason R.B., and Lopaschuk, Gary D.
- Subjects
OXIDATION of glucose ,FATTY acid oxidation ,HEART ,KETONES ,HEART metabolism - Abstract
Cardiac glucose oxidation is decreased in heart failure with reduced ejection fraction (HFrEF), contributing to a decrease in myocardial ATP production. In contrast, circulating ketones and cardiac ketone oxidation are increased in HFrEF. Since ketones compete with glucose as a fuel source, we aimed to determine whether increasing ketone concentration both chronically with the SGLT2 inhibitor, dapagliflozin, or acutely in the perfusate has detrimental effects on cardiac glucose oxidation in HFrEF, and what effect this has on cardiac ATP production. 8-week-old male C57BL6/N mice underwent sham or transverse aortic constriction (TAC) surgery to induce HFrEF over 3 weeks, after which TAC mice were randomized to treatment with either vehicle or the SGLT2 inhibitor, dapagliflozin (DAPA), for 4 weeks (raises blood ketones). Cardiac function was assessed by echocardiography. Cardiac energy metabolism was measured in isolated working hearts perfused with 5 mM glucose, 0.8 mM palmitate, and either 0.2 mM or 0.6 mM β-hydroxybutyrate (βOHB). TAC hearts had significantly decreased %EF compared to sham hearts, with no effect of DAPA. Glucose oxidation was significantly decreased in TAC hearts compared to sham hearts and did not decrease further in TAC hearts treated with high βOHB or in TAC DAPA hearts, despite βOHB oxidation rates increasing in both TAC vehicle and TAC DAPA hearts at high βOHB concentrations. Rather, increasing βOHB supply to the heart selectively decreased fatty acid oxidation rates. DAPA significantly increased ATP production at both βOHB concentrations by increasing the contribution of glucose oxidation to ATP production. Therefore, increasing ketone concentration increases energy supply and ATP production in HFrEF without further impairing glucose oxidation. [Display omitted] • Increased ketone concentration increases energy supply and fuel production in HFrEF. • Glucose oxidation is not further impaired with higher ketone concentrations. • ATP production is higher from increased contribution of glucose oxidation. • Cardiac efficiency is not increased. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart.
- Author
-
Uddin, Golam M., Karwi, Qutuba G., Pherwani, Simran, Gopal, Keshav, Wagg, Cory S., Biswas, Dipsikha, Atnasious, Mariam, Wu, Yikuan, Wu, Guoqing, Zhang, Liyan, Ho, Kim L., Pulinilkunnil, Thomas, Ussher, John R., and Lopaschuk, Gary D.
- Subjects
OXIDATION of glucose ,BRANCHED chain amino acids ,INSULIN ,INSULIN sensitivity ,INSULIN resistance ,HEART metabolism - Abstract
Branched chain amino acid (BCAA) oxidation is impaired in cardiac insulin resistance, leading to the accumulation of BCAAs and the first products of BCAA oxidation, the branched chain ketoacids. However, it is not clear whether it is the BCAAs, BCKAs or both that are mediating cardiac insulin resistance. To determine this, we produced mice with a cardiac-specific deletion of BCAA aminotransferase (BCATm
−/− ), the first enzyme in the BCAA oxidation pathway that is responsible for converting BCAAs to BCKAs. Eight-week-old BCATm cardiac specific knockout (BCATm−/− ) male mice and their α-MHC (myosin heavy chain) - Cre expressing wild type littermates (WT-Cre+/+ ) received tamoxifen (50 mg/kg i.p. 6 times over 8 days). At 16-weeks of age, cardiac energy metabolism was assessed in isolated working hearts. BCATm−/− mice have decreased cardiac BCAA oxidation rates, increased cardiac BCAAs and a reduction in cardiac BCKAs. Hearts from BCATm−/− mice showed an increase in insulin stimulation of glucose oxidation and an increase in p-AKT. To determine the impact of reversing these events, we perfused isolated working mice hearts with high levels of BCKAs, which completely abolished insulin-stimulated glucose oxidation rates, an effect associated with decreased p-AKT and inactivation of pyruvate dehydrogenase (PDH), the rate-limiting enzyme in glucose oxidation. This implicates the BCKAs, and not BCAAs, as the actual mediators of cardiac insulin resistance and suggests that lowering cardiac BCKAs can be used as a therapeutic strategy to improve insulin sensitivity in the heart. • Cardiac-specific BCATm deletion selectively increases BCAAs levels and decreases BCKAs levels. • Lowering cardiac BCKAs levels, not BCAAs, enhances cardiac insulin sensitivity. • Cardiac BCAA accumulation, triggers the mTOR signaling and cardiac hypertrophy in the BCATm knockout hearts. • Augmented levels of BCKAs, not BCAAs, abolish insulin-stimulated cardiac glucose oxidation. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.